1 min read
Nick McDonald
1 min read
AGC Biologics Acquires Commercial Facility, Expanding Cell & Gene Therapy Global Service Offerings
August 5, 2021 at 9:00 AM
1 min read
AGC Biologics Appoints Kevin Ingham as the new General Manager/Site Head of their Seattle, Washington Site
August 2, 2021 at 11:00 AM
4 min read
Chemomab Therapeutics and AGC Biologics Expand Partnership to Manufacture CM-101 for Phase II/III
June 23, 2021 at 5:30 AM
1 min read
AGC Biologics’ Heidelberg Facility to Further Supply Plasmid DNA for COVID-19 Vaccine
June 7, 2021 at 7:00 AM
2 min read
AGC Inc. Receives Best Acquisition Award for Adding the Former MolMed into AGC Biologics
May 19, 2021 at 10:06 AM
2 min read
Oculis Selects AGC Biologics’ Heidelberg Facility to Manufacture OCS-02
May 6, 2021 at 7:00 AM
1 min read
Horizon Therapeutics plc Selects AGC Biologics to Further Supply KRYSTEXXA® (pegloticase injection) at AGC’s Copenhagen Facility
April 30, 2021 at 7:00 AM
Read press release